AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI Is Already Changing Medical Coverage Decisions, and Journalists Need to Follow the Money
The Association of Health Care Journalists is urging reporters to pay closer attention to AI’s role in coverage decisions. As insurers and utilization managers use AI to sort claims and prior authorization requests, the real story is shifting from futuristic promises to real-world access, denials, and accountability.
Most U.S. Doctors Are Quietly Using AI Tools, and Patients May Not Realize It
NBC News reports that many U.S. doctors are already using AI tools in clinical practice, often without patients knowing. The story underscores a growing transparency gap between AI adoption and public awareness.
Patient trust may be the real bottleneck for AI healthcare adoption
EMJ reports that patient acceptance of AI in healthcare is shaped less by technical capability than by trust barriers. That finding matters because even strong performance claims can fail if patients believe the system is opaque, biased, or trying to replace human judgment. For hospitals, adoption is increasingly a communication problem as much as a technology problem.
Medicaid Prior Authorization Enters the AI Transparency Debate
MACPAC is calling for greater transparency in Medicaid AI prior authorization, bringing one of healthcare’s most contentious AI use cases into sharper public view. The issue is no longer just whether algorithms can speed reviews, but whether patients and clinicians can understand and challenge their outputs.
Healthcare AI’s trust gap is now a product problem, not just a PR problem
Healthcare Today’s piece on the trust gap with AI argues that skepticism is no longer just a communications challenge. In healthcare, trust increasingly depends on whether products are transparent, safe, and demonstrably useful in real workflows.
FDA Warns Against Suppressing Negative Trial Results as Transparency Enforcement Intensifies
The FDA has warned thousands of companies and researchers against suppressing unfavorable clinical trial results, signaling a tougher stance on transparency. The message is especially relevant as more healthcare innovation depends on data credibility.
FDA Reminds Sponsors and Researchers to Disclose Clinical Trial Results
The FDA is reminding sponsors and researchers about the requirement to disclose clinical trial results, putting transparency back in focus for the drug and device ecosystem. The move underscores that public accountability remains a core part of biomedical research, even as attention shifts toward faster development and AI-enabled discovery.
Public Trust in Healthcare AI Is Slipping at the Moment Adoption Is Accelerating
Medical Xpress reports survey findings that public trust in healthcare AI is declining. The mismatch between rapid enterprise deployment and softening public confidence could become one of the field’s biggest adoption constraints.
Bioethics Is Catching Up to Healthcare AI, and Informed Consent Is Becoming the Pressure Point
New bioethics commentary from The Hastings Center and Bioethics Today underscores how quickly ethical questions around AI in healthcare are moving from theory into operational relevance. A central theme is informed consent: patients may be affected by AI in ways that are clinically meaningful but poorly explained, inconsistently disclosed, or difficult to understand.
EFF Lawsuit Against CMS Puts AI Prior Authorization Under a Sharper Legal Microscope
The Electronic Frontier Foundation has sued CMS over an AI prior authorization demonstration, escalating legal scrutiny of algorithmic decision-making in public insurance programs. The case could become a major test of transparency, accountability and due process in healthcare automation.
Utah’s refill bot controversy shows why healthcare AI pilots can become governance crises
MedCity News examines the controversy around Utah’s AI-enabled prescription refill bot and researchers who challenged its performance and oversight. The story is significant because it illustrates how narrow workflow automation in healthcare can quickly escalate into disputes over transparency, evidence standards, and public-sector accountability.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.